Author:
Wang Cun,Jin Haojie,Gao Dongmei,Lieftink Cor,Evers Bastiaan,Jin Guangzhi,Xue Zheng,Wang Liqin,Beijersbergen Roderick L.,Qin Wenxin,Bernards René
Reference34 articles.
1. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2016
2. Genetic landscape and biomarkers of hepatocellular carcinoma;Zucman-Rossi;Gastroenterology,2015
3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献